(Q44921174)
Statements
1 reference
RFS2000 (9-nitrocamptothecin) in advanced small cell lung cancer, a phase II study of the EORTC New Drug Development Group (English)
1 reference
1 reference
C J A Punt
1 reference
M J A de Jonge
1 reference
W Fiedler
1 reference
B Baron
1 reference
D Lacombe
1 reference
P Fumoleau
1 reference
EORTC New Drug Development Group
1 reference
1 June 2004
1 reference
1 reference
40
1 reference
9
1 reference
1332-1334
1 reference
Identifiers
1 reference
1 reference